Prs24 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Ff/Vi and Umec/Vi in Patients With Copd: Healthcare Resource Utilization Data and Associated Costs – Germany
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2418
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV